Cargando…

Targeted validation: validating clinical prediction models in their intended population and setting

Clinical prediction models must be appropriately validated before they can be used. While validation studies are sometimes carefully designed to match an intended population/setting of the model, it is common for validation studies to take place with arbitrary datasets, chosen for convenience rather...

Descripción completa

Detalles Bibliográficos
Autores principales: Sperrin, Matthew, Riley, Richard D., Collins, Gary S., Martin, Glen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773429/
https://www.ncbi.nlm.nih.gov/pubmed/36550534
http://dx.doi.org/10.1186/s41512-022-00136-8
_version_ 1784855190301573120
author Sperrin, Matthew
Riley, Richard D.
Collins, Gary S.
Martin, Glen P.
author_facet Sperrin, Matthew
Riley, Richard D.
Collins, Gary S.
Martin, Glen P.
author_sort Sperrin, Matthew
collection PubMed
description Clinical prediction models must be appropriately validated before they can be used. While validation studies are sometimes carefully designed to match an intended population/setting of the model, it is common for validation studies to take place with arbitrary datasets, chosen for convenience rather than relevance. We call estimating how well a model performs within the intended population/setting “targeted validation”. Use of this term sharpens the focus on the intended use of a model, which may increase the applicability of developed models, avoid misleading conclusions, and reduce research waste. It also exposes that external validation may not be required when the intended population for the model matches the population used to develop the model; here, a robust internal validation may be sufficient, especially if the development dataset was large.
format Online
Article
Text
id pubmed-9773429
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97734292022-12-22 Targeted validation: validating clinical prediction models in their intended population and setting Sperrin, Matthew Riley, Richard D. Collins, Gary S. Martin, Glen P. Diagn Progn Res Commentary Clinical prediction models must be appropriately validated before they can be used. While validation studies are sometimes carefully designed to match an intended population/setting of the model, it is common for validation studies to take place with arbitrary datasets, chosen for convenience rather than relevance. We call estimating how well a model performs within the intended population/setting “targeted validation”. Use of this term sharpens the focus on the intended use of a model, which may increase the applicability of developed models, avoid misleading conclusions, and reduce research waste. It also exposes that external validation may not be required when the intended population for the model matches the population used to develop the model; here, a robust internal validation may be sufficient, especially if the development dataset was large. BioMed Central 2022-12-22 /pmc/articles/PMC9773429/ /pubmed/36550534 http://dx.doi.org/10.1186/s41512-022-00136-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Sperrin, Matthew
Riley, Richard D.
Collins, Gary S.
Martin, Glen P.
Targeted validation: validating clinical prediction models in their intended population and setting
title Targeted validation: validating clinical prediction models in their intended population and setting
title_full Targeted validation: validating clinical prediction models in their intended population and setting
title_fullStr Targeted validation: validating clinical prediction models in their intended population and setting
title_full_unstemmed Targeted validation: validating clinical prediction models in their intended population and setting
title_short Targeted validation: validating clinical prediction models in their intended population and setting
title_sort targeted validation: validating clinical prediction models in their intended population and setting
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773429/
https://www.ncbi.nlm.nih.gov/pubmed/36550534
http://dx.doi.org/10.1186/s41512-022-00136-8
work_keys_str_mv AT sperrinmatthew targetedvalidationvalidatingclinicalpredictionmodelsintheirintendedpopulationandsetting
AT rileyrichardd targetedvalidationvalidatingclinicalpredictionmodelsintheirintendedpopulationandsetting
AT collinsgarys targetedvalidationvalidatingclinicalpredictionmodelsintheirintendedpopulationandsetting
AT martinglenp targetedvalidationvalidatingclinicalpredictionmodelsintheirintendedpopulationandsetting